Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00003339 · COMPLETED

Trial details

NCT number: NCT00003339
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 1998-11-01
Primary completion: 1999-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.